Eclipse™ is a comprehensive treatment planning system that simplifies modern radiation therapy planning for all kinds of treatment, including 3D conformal, intensity-modulated radiation therapy (IMRT), electron, proton, and brachytherapy.
With the rich functionality in Eclipse, dosimetrists, physicists, and physicians can efficiently create, select, and verify the best treatment plans for their patients. In addition to ensuring high standards of care and effective protocols, Eclipse provides clinicians with the flexibility to quickly tailor plans for each patient.
Designed to meet the needs of modern clinics and evolving technologies, Eclipse supports advanced processes such as image-guided radiation therapy (IGRT) and Dynamic Adaptive Radiation Therapy (DART™). The efficiency and cost effectiveness of Eclipse enables growing clinics to adopt advanced techniques, protecting investments while improving the quality of care.
Thursday, August 27, 2009
oncology
Port access Needles
Oncology non-coring color coded by needle gauge and needle length. Fixed wings allow for an easy grasp and comfortable insertion technique. Competitively priced and available from stock.
Extension Sets, Adapters and I.V. Filters
Extension sets and adapters of various sizes, lengths and priming volumes. Bifercated, Trifercated, and ' T ' configurations are available with and without filters
PICC Catheters
Our catheter is complete, convenient, and cost effective. The fine quality instruments included in this tray are for ease of catheter placement. The PICC uses a unique coaxial silicone extrusion method. This means that the X-ray opaque material is sealed between coaxial layers of pure silicone. The result is a smoother surface and improved bio-compatability when compared to a conventional silicone catheter. Available with or without guidewire and your choice of splitting needle or peelable cannula. Our PICC Kit contains all the components, dressings required for a efficient catheter placement.
Blood Draw Safety Syringes
These unique devices virtually eliminate your exposure to contaminated needles during the blood draw procedure. Our Blood Collection Device and Safety Syringe provide automated retraction of the needle into the syringe barrel to instantly remove the needle directly from the patient.
Custom Procedure Trays
Procedure trays for any application are available in quantities as small as ten (10) trays. You specify the items to be included in the tray. We build, sterilize and store the tray for you. If you are doing procedures that require multiple items to be gathered, why not stop wasting time and storage space. Give us the specifications of the tray along with your anticipated annual purchase volume and we'll give you a sample tray with your price
Oncology non-coring color coded by needle gauge and needle length. Fixed wings allow for an easy grasp and comfortable insertion technique. Competitively priced and available from stock.
Extension Sets, Adapters and I.V. Filters
Extension sets and adapters of various sizes, lengths and priming volumes. Bifercated, Trifercated, and ' T ' configurations are available with and without filters
PICC Catheters
Our catheter is complete, convenient, and cost effective. The fine quality instruments included in this tray are for ease of catheter placement. The PICC uses a unique coaxial silicone extrusion method. This means that the X-ray opaque material is sealed between coaxial layers of pure silicone. The result is a smoother surface and improved bio-compatability when compared to a conventional silicone catheter. Available with or without guidewire and your choice of splitting needle or peelable cannula. Our PICC Kit contains all the components, dressings required for a efficient catheter placement.
Blood Draw Safety Syringes
These unique devices virtually eliminate your exposure to contaminated needles during the blood draw procedure. Our Blood Collection Device and Safety Syringe provide automated retraction of the needle into the syringe barrel to instantly remove the needle directly from the patient.
Custom Procedure Trays
Procedure trays for any application are available in quantities as small as ten (10) trays. You specify the items to be included in the tray. We build, sterilize and store the tray for you. If you are doing procedures that require multiple items to be gathered, why not stop wasting time and storage space. Give us the specifications of the tray along with your anticipated annual purchase volume and we'll give you a sample tray with your price
Conquering the lethal complication of bone marrow transplantation
NFCR Fellow Curt Civin, M.D.
University of Maryland School of Medicine
Bone marrow transplantation is a life-saving procedure used in patients with leukemia and other diseases to replenish their vital blood-forming system, which is often destroyed by high-dose chemotherapy treatment. However, the very same procedure may cost a patient’s life if a severe complication known as the graft-versus-host disease (GVHD) occurs. When a patient receives a bone marrow transplant from a donor (allogeneic transplant), a subset of the immune cells from the transplant can be activated to mount vigorous immunologic attacks on the patient’s (the recipient’s) tissues, causing GVHD. This side effect could be lethal, which greatly limits the clinical application of allogeneic bone marrow transplantation.
NFCR Fellow Curt Civin, M.D. (formerly at the Johns Hopkins University School of Medicine) and his team have developed a unique strategy in the laboratory which sends the anti-recipient immune cells onto a suicidal path, while keeping intact the “recipient-friendly” cells from the transplant, which is essential for successful blood replenishment in the patient. Recently, in a project supported by NFCR and another sponsor, he and his team have successfully completed preclinical tests with this approach using human cells. Now this promising treatment strategy is one step away from being launched into clinical tests in patients, giving them hope of conquering the complications during precious bone marrow transplantation. The work of Dr. Civin was recently published in the Journal of Immunology.
University of Maryland School of Medicine
Bone marrow transplantation is a life-saving procedure used in patients with leukemia and other diseases to replenish their vital blood-forming system, which is often destroyed by high-dose chemotherapy treatment. However, the very same procedure may cost a patient’s life if a severe complication known as the graft-versus-host disease (GVHD) occurs. When a patient receives a bone marrow transplant from a donor (allogeneic transplant), a subset of the immune cells from the transplant can be activated to mount vigorous immunologic attacks on the patient’s (the recipient’s) tissues, causing GVHD. This side effect could be lethal, which greatly limits the clinical application of allogeneic bone marrow transplantation.
NFCR Fellow Curt Civin, M.D. (formerly at the Johns Hopkins University School of Medicine) and his team have developed a unique strategy in the laboratory which sends the anti-recipient immune cells onto a suicidal path, while keeping intact the “recipient-friendly” cells from the transplant, which is essential for successful blood replenishment in the patient. Recently, in a project supported by NFCR and another sponsor, he and his team have successfully completed preclinical tests with this approach using human cells. Now this promising treatment strategy is one step away from being launched into clinical tests in patients, giving them hope of conquering the complications during precious bone marrow transplantation. The work of Dr. Civin was recently published in the Journal of Immunology.
Subscribe to:
Comments (Atom)
richprt.fast earning
LOTTERYPTC.EASY TO EARN
earning with alertpay
earn money
